Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06540287 · ClinicalTrials.gov registry record

Molecular Optimization Via Exercise (MOVE)

A clinical trial of Aging, sponsored by Buck Institute for Research on Aging.

Recruiting
Registry status
80
Enrollment target
1
Study location

NCT06540287 is a study of Aging that is actively recruiting participants, run by Buck Institute for Research on Aging. The registered enrollment target is 80 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06540287, a study of Aging, is actively recruiting participants, sponsored by Buck Institute for Research on Aging.

RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function testing and body composition.

Conditions Studied

Interventions

  • OTHER Observational

Study Locations (1)

California

  • Buck Institute for Research on Aging - Novato

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-09-19
Est. Completion 2027-05

What the Registry Record Tells You About NCT06540287

The ClinicalTrials.gov registry entry for NCT06540287 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The listed sponsor is Buck Institute for Research on Aging, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT06540287 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06540287 about?

NCT06540287 is a clinical study titled "Molecular Optimization Via Exercise (MOVE)". This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function t...

What is the current status of trial NCT06540287?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-09-19. Estimated completion is 2027-05.

What conditions does trial NCT06540287 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT06540287?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT06540287?

This trial is sponsored by Buck Institute for Research on Aging, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06540287 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.